Overview
Dr. Lechtzin is a pulmonary and critical care medicine physician. He directs the Adult CF program and the neuromuscular pulmonary clinic at Johns Hopkins and is an expert in the treatment of cystic fibrosis, pulmonary complications of neuromuscular disease and the care of critically ill patients in the Medical ICU. He is a member of the Longcope Firm Faculty and provides teaching to medical students and residents at Johns Hopkins.
Dr. Lechtzin is highly rated in 3 conditions, according to our data. His top areas of expertise are Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, Lung Transplant, and Endoscopy.
His clinical research consists of co-authoring 86 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
601 North Caroline Street, Floor 7, Floor 7, Baltimore, MD 21287
601 North Caroline Street, Floor 5, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Johns Hopkins Bayview Medical Center
Dr. Danoff is an Assistant Professor in the Division of Pulmonary and Critical Care Medicine and Co-Director of the Hopkins Interstitial Lung Disease Clinic. She is a specialist in diseases causing fibrosis or scarring in the lung, particularly those associated with autoimmune diseases including myositis. Dr. Danoff is highly rated in 12 conditions, according to our data. Her top areas of expertise are Interstitial Lung Disease, Acute Interstitial Pneumonia, Pulmonary Fibrosis, Endoscopy, and Lung Transplant.
Inova Fairfax Medical Campus
Steven Nathan is a Pulmonary Medicine provider in Falls Church, Virginia. Dr. Nathan is highly rated in 18 conditions, according to our data. His top areas of expertise are Idiopathic Pulmonary Fibrosis, Acute Interstitial Pneumonia, Interstitial Lung Disease, Lung Transplant, and Prostatectomy.
Johns Hopkins Outpatient Center
Paul M. Hassoun, M.D., is professor of medicine at the Johns Hopkins University School of Medicine and the director of the pulmonary hypertension program at Johns Hopkins Hospital. He received his medical degree from the Faculté de Médecine Lariboisière-Saint Louis at the University of Paris, France, completed an internship and residency at Brigham and Women’s Hospital and a fellowship in Pulmonary and Critical Care Medicine at Massachusetts General Hospital, both at Harvard Medical School. He was on faculty in the pulmonary division at New England Medical Center/Tufts University School of Medicine (Tufts-NEMC) in Boston, MA, until 2002 when he joined the division of pulmonary and critical care medicine at Johns Hopkins University. Dr. Hassoun has served or currently serves on numerous American Thoracic Society (ATS) assemblies and committees, including the Pulmonary Circulation Long Range Planning Committee, the Pulmonary Circulation Program Committee (for which he served as chair for 2008-2009), the ATS Scientific Advisory Council, Pulmonary Circulation Leadership Committee, and the American College of Chest Physicians Vascular Steering Committee. He served as the ATS Pulmonary Circulation chair (2011-2012) and on the ATS Publications Policy Committee. He was recently elected president of the Pulmonary Vascular Research Institute (PVRI; 2018-2019). Dr. Hassoun has held numerous editorial activities including serving on the editorial board of the American Journal of Respiratory and Critical Medicine (2010 to present), CHEST (2006-2015) and the European Respiratory Review (2008-2015). He currently serves as associate editor of the European Respiratory Journal (2013-present) and has served as associate editor for the Journal of Clinical Investigation (2017-2022). Dr. Hassoun is highly rated in 7 conditions, according to our data. His top areas of expertise are Pulmonary Hypertension, Systemic Sclerosis (SSc), Pulmonary Veno-Occlusive Disease, Cerebral Hypoxia, and Lung Transplant.
Frequently Asked Questions about Dr. Noah Lechtzin
How do I make an appointment with Dr. Noah Lechtzin?
You can book an appointment with Dr. Noah Lechtzin by calling their office at 410-550-5864. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Noah Lechtzin a top-rated expert for Cystic Fibrosis?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Noah Lechtzin is classified as an Elite expert for Cystic Fibrosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Noah Lechtzin specialize in?
While Dr. Noah Lechtzin is a Pulmonary Medicine, they have specific expertise in Cystic Fibrosis, Secondary Immunodeficiency (SID), and Newborn Jaundice. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pulmonary Medicine.
Does Dr. Noah Lechtzin participate in research or clinical trials?
Yes. Dr. Noah Lechtzin has published 86 articles and abstracts on conditions like Cystic Fibrosis. You can view a list of Dr. Noah Lechtzin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Noah Lechtzin accept my insurance?
Dr. Noah Lechtzin accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 410-550-5864 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Cystic FibrosisDr. Lechtzin isElite. Learn about Cystic Fibrosis.
- Distinguished
- Secondary Immunodeficiency (SID)Dr. Lechtzin isDistinguished. Learn about Secondary Immunodeficiency (SID).
- Advanced
- Newborn JaundiceDr. Lechtzin isAdvanced. Learn about Newborn Jaundice.
- Experienced
- Acute Interstitial PneumoniaDr. Lechtzin isExperienced. Learn about Acute Interstitial Pneumonia.
- BronchiectasisDr. Lechtzin isExperienced. Learn about Bronchiectasis.
- EndoscopyDr. Lechtzin isExperienced. Learn about Endoscopy.
- Idiopathic Pulmonary FibrosisDr. Lechtzin isExperienced. Learn about Idiopathic Pulmonary Fibrosis.
- Interstitial Lung DiseaseDr. Lechtzin isExperienced. Learn about Interstitial Lung Disease.
- Lung TransplantDr. Lechtzin isExperienced. Learn about Lung Transplant.